Clinical trial
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of…
NCT00319046 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00319046 |
|---|---|
| Title | Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease |
| Official title | Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gaucher Disease Type 1 |
| Intervention type | Drug |
| Interventions | Miglustat |
| Enrollment | 42 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 4, 2025 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: